IV Thrombolysis After Dabigatran Reversal by Idarucizumab
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
Frontiers in Neurology
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Intravenous Thrombolysis After Dabigatran Reversal by Idarucizumab: A Systematic Review of the Literature
Front Neurol 2021 Jul 01;[EPub Ahead of Print], S Frol, D Sagris, J Pretnar Oblak, M Šabovič, G NtaiosFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.